Timi Adetona

With a distinguished career spanning over 25 years in regulatory affairs, including 8 years in Regulatory Affairs Consulting, Timi has established a remarkable reputation for expertise and leadership in the pharmaceutical industry through a career birthed in Procter & Gamble and matured in Voisin Consulting.

Timi has acquired significant knowledge of EMA, UK and Swiss regulations and procedures and has successfully managed several MAA submissions for drugs and biologics, and innovative nutritional products in Europe, as well as statutory regulatory requirements in global markets including the USA and emerging markets. 

Timi has substantial experience in all steps of product development from preclinical to life-cycle management, including those involving specialized conditions such as orphan drug designations, accelerated or fast-track assessment procedures and compassionate use programs. In one of his recent roles as Senior Director of Regulatory Affairs, Timi served as a regulatory consultant to EspeRare, a Swiss foundation dedicated to rare paediatric diseases and paediatric medical device product development.

Prior to this, he held the position of Director of Regulatory Affairs for Drugs, Biologics, Nutritional, and Borderline Products at Voisin Consulting, a prominent consulting firm in Europe, where he played crucial role in validating and providing second opinions on regulatory strategy proposals for engaging with the European Medicines Agency (EMA), the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), and Switzerland’s SwissMedic.

Timi possesses tertiary education and training in various health fields, including Public Health, as well as Human Nutrition (University of Ibadan, Nigeria); Pollution and Environmental Control (University of Manchester, UK) and Mental Health (University of Wolverhampton, UK). This multidisciplinary background has equipped him with a broad perspective and deep understanding of health-related regulatory affairs.

Over a recent two and a half years period, Timi held a very senior regulatory position with Sciensus, a prominent Pharma services and rare products company based in the UK. Here, Timi was entrusted with ensuring comprehensive regulatory compliance, and he successfully led a cross-functional team comprising Quality, Pharmacovigilance, and Logistics operatives. Under his direction, the team effectively delivered both Early Access Programs (EAP) and commercial products to patients throughout Europe and beyond.

Timi's extensive experience, combined with his innovative approach and commitment to excellence, has made him a highly respected figure in the field of regulatory affairs. He contributes to pertinent regulatory affairs topics in scientific/medical journals; delivers lectures in regulatory affairs seminars and conferences; and is a member of The Organisation for Professionals in Regulatory Affairs (TOPRA).